InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Kronenfeld Mark A., 董事. Director active across 1 company, notably Pacira BioSciences, Inc.. Aggregated, 7 disclosures have been logged. History available since 9 June 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kronenfeld Mark A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
6,163 股0Common StockSEC:0001628280-26-019892:0
9,999 股0Common StockSEC:0001396814-25-000087:0
5,230 股0Common StockSEC:0001396814-24-000072:0
1,775 股0Common StockSEC:0001209191-23-038024:0
15,000 股@ US$29.90100.0% 占其流量Common StockSEC:0001209191-23-036270:0
1,160 股0Common StockSEC:0001209191-22-035224:0
1,066 股0Common StockSEC:0001209191-21-040085:0
7 条申报中的 7 条
About Kronenfeld Mark A.
Mark A. Kronenfeld is a Director at Pacira BioSciences, Inc., a biopharmaceutical company focused on developing therapeutic solutions. As a board member, he contributes to the company's strategy and oversight of its operations, ensuring that shareholder interests are protected.
